Watson Pharmaceuticals, Inc. - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Watson Pharmaceuticals, Inc. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Watson Pharmaceuticals, Inc.. The Group's principal activities are to develop, manufacture and market generic and brand pharmaceutical products. The Group operates through three segments: Branded, Generic and Distribution. The Branded segment serves the specialty markets in urology and nephrology. The Generic pharmaceutical products segment includes off-patent pharmaceutical products that are therapeutically equivalent to proprietary products. Distribution Segment consists of Anda, Anda Pharmaceuticals and Valmed. The Group markets their products to pharmaceutical wholesalers, drug distributors and chain drug stores.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report